Benedict P Ancock, MD
Cardiovascular Disease (Cardiology) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 2 carriers
- Office
- 1
- Since medical school
- 21 years
- Graduated 2005
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus · Marinhealth Medical Center · Novato Community Hospital · Sonoma Valley Hospital. That is not proof they admit you there this week.
Plans that list them
11 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ancock’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A118391 · Current
Licensed to practise in California · since 2011 · expires 2027-06-30 · University of London, Imperial College School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiology
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Internal Medicine
- American Board of Nuclear Medicine - Nuclear Medicine
- American Board of Preventive Medicine - Public Health and General Preventive Medicine
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sonoma Valley HospitalSonoma, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sonoma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.63 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 35 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.6 · 345 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 713 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.94) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.86 (0 to 18.76) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.45) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 540 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 60 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.2 to 17.9) · 486 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 83 cases | No different | Jan 2024 – Dec 2024 |
What patients said (164 patients answered, 31% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 84% |
| Doctors "always" listened carefully | 88% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$453,607
Medicare paid this office $453,607 for 1,881 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 776 | $150,299 | $106 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | 16 | $89,706 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $34,937 | $99 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | 16 | $29,906 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 491 | $27,030 | $55 |
See all 32 services
| Return visit (30+ min) | 776 | $150,299 | $106 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | 16 | $89,706 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $34,937 | $99 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | 16 | $29,906 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 491 | $27,030 | $55 |
| Long return visit (40+ min) | 78 | $16,564 | $156 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 670 | $15,946 | $14 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $12,137 | $140 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 120 | $10,714 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 163 | $10,054 | $58 |
| New patient visit (45+ min) | 44 | $6,057 | $138 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 29 | $5,549 | $185 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 75 | $4,791 | $63 |
| Telephone medical discussion with physician, 11-20 minutes | 45 | $4,313 | $77 |
| Critical care, first 30-74 minutes | 20 | $3,848 | $167 |
| Anticoagulant management of patient taking warfarin | 18 | $3,497 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 264 | $3,379 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 115 | $2,582 | $21 |
| Long return visit (40+ min) | 18 | $2,455 | $123 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,683 | $89 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 76 | $1,581 | $19 |
| Short return visit (20+ min) | 21 | $1,492 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,478 | $64 |
| Ultrasound of heart blood flow, valves and chambers | 77 | $1,041 | $13 |
| Heart rhythm recording of continous external ekg over 8-15 days | 74 | $943 | $12 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 44 | $570 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 27 | $373 | $14 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 14 | $298 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 78 | $182 | $2 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $160 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $105 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $65 | $2 |
Who their Medicare patients are
1,881 Original Medicare patients in 2024. Average age 79 · Under 65 1% · 85 and older 21% · Women 45% · Also on Medicaid 10% · Health risk score 1.34. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 49% · Atrial fibrillation 43% · Heart failure 29% · Chronic kidney disease 28% · Diabetes 22% · Depression 20% · Cancer 18% · Stroke 16% · COPD 12% · Dementia 8%.
The office billed $2,555,621, Medicare allowed $598,234 and paid $453,607; for 6,935 services of 46 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,881 | 6,935 | 79 | 1.34 | $2,555,621 | $453,607 |
| 2023 | 1,709 | 5,122 | 78 | 1.35 | $2,195,394 | $380,449 |
| 2022 | 1,542 | 4,793 | 78 | 1.35 | $2,038,223 | $355,357 |
| 2021 | 1,633 | 4,967 | 78 | 1.36 | $2,042,993 | $336,520 |
| 2020 | 1,267 | 3,435 | 78 | 1.39 | $1,447,860 | $222,243 |
| 2019 | 1,787 | 4,258 | 77 | 1.55 | $1,814,737 | $250,404 |
| 2018 | 1,362 | 4,086 | 77 | 1.44 | $664,656 | $247,647 |
| 2017 | 1,396 | 3,742 | 76 | 1.48 | $582,075 | $200,199 |
| 2016 | 471 | 1,119 | 76 | 1.39 | $189,812 | $61,351 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 33 services
| Return visit (30+ min) | 680 | $121,296 | $105 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | 20 | $76,995 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 127 | $26,976 | $101 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 445 | $26,040 | $58 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | 20 | $25,777 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $12,066 | $144 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 187 | $11,498 | $58 |
| Long return visit (40+ min) | 59 | $10,255 | $158 |
| New patient visit (45+ min) | 64 | $8,682 | $136 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 63 | $6,221 | $24 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 32 | $6,149 | $186 |
| Critical care, first 30-74 minutes | 15 | $4,529 | $189 |
| Telephone medical discussion with physician, 11-20 minutes | 50 | $4,017 | $69 |
| Anticoagulant management of patient taking warfarin | 25 | $3,950 | $9 |
| Ultrasound of heart with probe in esophagus, with report | 44 | $3,833 | $85 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 46 | $3,230 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 236 | $3,072 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,757 | $66 |
| Short return visit (20+ min) | 34 | $2,752 | $74 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 94 | $2,092 | $22 |
| External shock to heart to regulate heart beat | 16 | $1,484 | $93 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 68 | $1,456 | $20 |
| New patient visit (30+ min) | 12 | $1,208 | $101 |
| Heart rhythm recording of continous external ekg over 8-15 days | 76 | $952 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 47 | $711 | $15 |
| Ultrasound of heart blood flow, valves and chambers | 47 | $696 | $14 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 35 | $470 | $12 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 19 | $413 | $22 |
| Ultrasound of heart, follow-up | 12 | $253 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $199 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $131 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 50 | $129 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 46 | $121 | $3 |
2022: 33 services
| Return visit (30+ min) | 572 | $132,969 | $116 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | 22 | $47,697 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 149 | $27,657 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 333 | $17,618 | $53 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | 22 | $16,113 | $103 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 218 | $13,447 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $12,429 | $155 |
| Long return visit (40+ min) | 58 | $11,524 | $162 |
| New patient visit (45+ min) | 80 | $10,776 | $135 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 30 | $5,723 | $191 |
| Critical care, first 30-74 minutes | 18 | $5,599 | $207 |
| Short return visit (20+ min) | 63 | $5,415 | $77 |
| Transitional care management services for problem of high complexity | 17 | $4,263 | $251 |
| Telephone medical discussion with physician, 11-20 minutes | 43 | $4,153 | $81 |
| Ultrasound of heart with probe in esophagus, with report | 49 | $3,964 | $79 |
| Anticoagulant management of patient taking warfarin | 27 | $3,751 | $8 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 59 | $3,699 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 271 | $3,323 | $11 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $2,976 | $60 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 41 | $2,689 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 84 | $1,806 | $21 |
| New patient visit (30+ min) | 15 | $1,400 | $93 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 60 | $1,247 | $20 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $972 | $40 |
| Ultrasound of heart blood flow, valves and chambers | 59 | $760 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 53 | $736 | $14 |
| Heart rhythm recording of continous external ekg over 8-15 days | 45 | $596 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 30 | $408 | $14 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 24 | $386 | $14 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 17 | $374 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 30 | $269 | $9 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 54 | $135 | $2 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 59 | $132 | $2 |
2021: 39 services
| Return visit (30+ min) | 594 | $125,384 | $104 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | 13 | $30,503 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 145 | $23,326 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 321 | $18,632 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 89 | $15,091 | $166 |
| Long return visit (40+ min) | 66 | $13,568 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 213 | $13,345 | $61 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | 13 | $10,645 | $102 |
| New patient visit (45+ min) | 68 | $9,601 | $141 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 39 | $7,665 | $197 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 106 | $7,045 | $66 |
| Anticoagulant management of patient taking warfarin | 34 | $5,409 | $9 |
| Critical care, first 30-74 minutes | 22 | $4,830 | $186 |
| Ultrasound of heart with probe in esophagus, with report | 48 | $4,363 | $89 |
| Short return visit (20+ min) | 57 | $4,332 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 246 | $3,908 | $13 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 53 | $3,745 | $71 |
| Telephone medical discussion with physician, 11-20 minutes | 60 | $3,709 | $57 |
| Initial hospital observation care per day, typically 70 minutes | 22 | $3,357 | $153 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 108 | $2,660 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $2,404 | $62 |
| Transitional care management services for problem of at least moderate complexity | 11 | $2,079 | $189 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 30 | $2,062 | $24 |
| External shock to heart to regulate heart beat | 15 | $1,433 | $96 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 61 | $1,348 | $21 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 17 | $1,243 | $73 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 65 | $1,230 | $19 |
| Follow-up observation care per day, typically 35 minutes | 13 | $1,174 | $90 |
| Ultrasound of heart blood flow, valves and chambers | 63 | $989 | $15 |
| Heart rhythm recording of continous external ekg over 8-15 days | 55 | $872 | $15 |
| New patient visit (30+ min) | 11 | $846 | $77 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 66 | $838 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 55 | $815 | $15 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 29 | $476 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $322 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 31 | $244 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $216 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 64 | $177 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 56 | $145 | $3 |
2020: 35 services
| Return visit (30+ min) | 541 | $100,730 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 278 | $16,251 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 101 | $13,965 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $12,917 | $170 |
| Telephone medical discussion with physician, 11-20 minutes | 81 | $7,761 | $67 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 117 | $7,350 | $62 |
| New patient visit (45+ min) | 60 | $6,991 | $117 |
| Transitional care management services for problem of high complexity | 20 | $4,851 | $221 |
| Short return visit (20+ min) | 63 | $4,285 | $60 |
| Ultrasound of heart with probe in esophagus, with report | 36 | $3,519 | $95 |
| Anticoagulant management of patient taking warfarin | 39 | $3,494 | $10 |
| Long return visit (40+ min) | 24 | $3,463 | $124 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 50 | $3,373 | $67 |
| Critical care, first 30-74 minutes | 12 | $3,211 | $189 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 137 | $3,193 | $22 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 14 | $3,011 | $201 |
| Transitional care management services for problem of at least moderate complexity | 15 | $2,695 | $168 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 160 | $2,642 | $14 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $2,551 | $62 |
| External ekg recording for more than 48 hours up to 21 days | 73 | $1,815 | $24 |
| Initial hospital observation care per day, typically 70 minutes | 12 | $1,755 | $146 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 24 | $1,706 | $71 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 22 | $947 | $24 |
| New patient visit (30+ min) | 13 | $923 | $71 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 39 | $758 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 41 | $692 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 38 | $495 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 26 | $386 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $277 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $213 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 25 | $192 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $143 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | $121 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $88 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $67 | $3 |
2019: 28 services
| Return visit (30+ min) | 510 | $95,916 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 136 | $20,894 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 318 | $19,745 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 99 | $16,938 | $169 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 205 | $13,269 | $63 |
| New patient visit (45+ min) | 75 | $10,354 | $138 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 106 | $7,045 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $6,851 | $61 |
| Short return visit (20+ min) | 93 | $6,435 | $59 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 27 | $5,231 | $194 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 69 | $4,317 | $22 |
| Long return visit (40+ min) | 27 | $3,918 | $122 |
| Ultrasound of heart with probe in esophagus, with report | 39 | $3,904 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 227 | $3,863 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 450 | $3,739 | $7 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 49 | $3,451 | $70 |
| External ekg recording for more than 48 hours up to 21 days | 117 | $2,996 | $24 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 117 | $2,765 | $22 |
| External shock to heart to regulate heart beat | 25 | $2,357 | $94 |
| Transitional care management services for problem of at least moderate complexity | 14 | $2,193 | $146 |
| Electrocardiogram (ecg) 2-day continuous | 46 | $1,219 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 47 | $1,139 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 60 | $1,120 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 50 | $755 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 60 | $751 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 41 | $691 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 50 | $134 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | $120 | $3 |
2018: 30 services
| Return visit (30+ min) | 376 | $80,313 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 119 | $28,938 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $15,208 | $177 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 223 | $14,319 | $63 |
| Short return visit (20+ min) | 182 | $13,930 | $58 |
| Long return visit (40+ min) | 78 | $13,039 | $130 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 149 | $9,970 | $64 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 79 | $8,310 | $23 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 99 | $6,697 | $68 |
| New patient visit (45+ min) | 48 | $6,611 | $138 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 81 | $5,864 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $5,146 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 232 | $4,184 | $15 |
| Transitional care management services for problem of at least moderate complexity | 26 | $3,880 | $149 |
| Ultrasound of heart with probe in esophagus, with report | 36 | $3,414 | $95 |
| External shock to heart to regulate heart beat | 25 | $2,511 | $97 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 95 | $1,854 | $19 |
| External ekg recording for more than 48 hours up to 21 days | 60 | $1,621 | $27 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 172 | $1,552 | $7 |
| Electrocardiogram (ecg) 2-day continuous | 51 | $1,476 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 60 | $1,451 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 51 | $1,308 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 95 | $1,244 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 78 | $1,216 | $16 |
| Ultrasound of heart blood flow, valves and chambers | 45 | $729 | $16 |
| Ct scan of heart with evaluation of blood vessel calcium | 28 | $725 | $26 |
| Hospital discharge day management, 30 minutes or less | 11 | $713 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 83 | $226 | $3 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $195 | $18 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 45 | $127 | $3 |
2017: 33 services
| Return visit (30+ min) | 264 | $49,213 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 115 | $23,589 | $90 |
| Short return visit (20+ min) | 178 | $14,353 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $14,135 | $168 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 195 | $10,286 | $52 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 104 | $9,351 | $23 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 121 | $8,167 | $67 |
| New patient visit (45+ min) | 56 | $7,328 | $131 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 128 | $7,312 | $55 |
| Long return visit (40+ min) | 38 | $6,157 | $118 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 79 | $5,643 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $5,473 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 191 | $3,376 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 280 | $2,319 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 115 | $2,229 | $19 |
| External shock to heart to regulate heart beat | 22 | $2,222 | $97 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,099 | $91 |
| Ct scan of blood vessels and grafts of heart with contrast | 15 | $1,557 | $104 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 115 | $1,494 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 79 | $1,255 | $16 |
| External ekg recording for more than 48 hours up to 21 days | 41 | $1,102 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 41 | $992 | $24 |
| Ct scan of heart with evaluation of blood vessel calcium | 36 | $907 | $25 |
| Programming of dual lead pacemaker system | 25 | $834 | $31 |
| Electrocardiogram (ecg) 2-day continuous | 27 | $756 | $26 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 28 | $709 | $24 |
| Hospital discharge day management, 30 minutes or less | 11 | $639 | $58 |
| Ultrasound of heart blood flow, valves and chambers | 35 | $547 | $16 |
| Short return visit | 12 | $469 | $39 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $368 | $19 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $347 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 78 | $216 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 35 | $95 | $3 |
2016: 21 services
| Return visit (30+ min) | 71 | $8,071 | $97 |
| New patient visit (45+ min) | 49 | $7,030 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $5,993 | $62 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 47 | $3,814 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 64 | $3,558 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,506 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 44 | $3,035 | $69 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,627 | $175 |
| Short return visit (20+ min) | 38 | $2,585 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 41 | $2,279 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 99 | $1,651 | $16 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $1,572 | $71 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 19 | $1,556 | $82 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 45 | $874 | $19 |
| Programming of dual lead pacemaker system | 23 | $830 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 45 | $570 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $355 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 35 | $272 | $7 |
| Ultrasound of heart blood flow, valves and chambers | 14 | $226 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $62 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $39 | $3 |
Medicaid work
$10,241 in 2024
Medicaid paid $10,241 for 155 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 125 | $8,835 |
| Return visit (30+ min) | 30 | $1,406 |
| 2024 | 155 | 2 | 21 | $10,241 |
| 2023 | 118 | 3 | 22 | $7,015 |
| 2022 | 85 | 1 | 22 | $5,505 |
| 2021 | 132 | 3 | 23 | $6,129 |
| 2020 | 72 | 3 | 20 | $2,459 |
| 2019 | 147 | 2 | 27 | $3,279 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 79 | $5,512 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 26 | $1,138 |
| Return visit (30+ min) | 13 | $366 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 85 | $5,505 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 75 | $4,259 |
| Return visit (30+ min) | 44 | $1,648 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 13 | $221 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 38 | $2,038 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 21 | $326 |
| Return visit (30+ min) | 13 | $95 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 132 | $2,265 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 15 | $1,014 |
Drugs they prescribed that Part D paid
$1,182,524
Pharmacies billed $1,182,524 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 6,261) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
5,379 generic and 882 brand-name prescriptions · $1,182,524 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 445 | $635,004 | $1,427 |
| Xarelto | 156 | $200,714 | $1,287 |
| Multaq | 48 | $68,891 | $1,435 |
| Repatha Sureclick | 37 | $42,394 | $1,146 |
| Entresto | 24 | $30,651 | $1,277 |
See all 58 drugs
| Eliquis | 445 | $635,004 | $1,427 |
| Xarelto | 156 | $200,714 | $1,287 |
| Multaq | 48 | $68,891 | $1,435 |
| Repatha Sureclick | 37 | $42,394 | $1,146 |
| Entresto | 24 | $30,651 | $1,277 |
| Praluent | 19 | $23,565 | $1,240 |
| Jardiance | 17 | $20,190 | $1,188 |
| Ezetimibe | 304 | $11,395 | $37 |
| Metoprolol | 615 | $10,770 | $18 |
| Brilinta | 11 | $10,668 | $970 |
| Atorvastatin | 825 | $9,410 | $11 |
| Vascepa | 20 | $8,439 | $422 |
| Rosuvastatin | 529 | $7,838 | $15 |
| Amlodipine Besylate | 528 | $4,452 | $8 |
| Carvedilol Er | 13 | $3,670 | $282 |
| Losartan | 313 | $3,496 | $11 |
| Nebivolol | 33 | $2,781 | $84 |
| Lisinopril | 226 | $2,389 | $11 |
| Pravastatin | 124 | $2,374 | $19 |
| Potassium Chloride | 89 | $2,234 | $25 |
| Digoxin | 70 | $2,030 | $29 |
| Diltiazem 24hr Er (Cd) | 61 | $1,930 | $32 |
| Olmesartan Medoxomil | 36 | $1,695 | $47 |
| Irbesartan | 42 | $1,685 | $40 |
| Isosorbide Mononitrate Er | 65 | $1,599 | $25 |
| Omega-3 Acid Ethyl Esters | 20 | $1,586 | $79 |
| Carvedilol | 103 | $1,255 | $12 |
| Ranolazine Er | 14 | $1,140 | $81 |
| Midodrine | 13 | $1,101 | $85 |
| Valsartan | 43 | $1,044 | $24 |
| Clopidogrel | 76 | $1,013 | $13 |
| Furosemide | 167 | $973 | $6 |
| Hydrochlorothiazide | 157 | $953 | $6 |
| Chlorthalidone | 44 | $943 | $21 |
| Warfarin | 60 | $860 | $14 |
| Metoprolol | 143 | $805 | $6 |
| Spironolactone | 55 | $747 | $14 |
| Hydralazine | 39 | $700 | $18 |
| Diltiazem | 15 | $687 | $46 |
| Ramipril | 43 | $676 | $16 |
| Candesartan Cilexetil | 14 | $651 | $47 |
| Amiodarone | 38 | $642 | $17 |
| Nitroglycerin | 31 | $536 | $17 |
| Verapamil Er | 12 | $488 | $41 |
| Torsemide | 18 | $483 | $27 |
| Simvastatin | 34 | $411 | $12 |
| Sotalol | 19 | $372 | $20 |
| Benazepril | 23 | $316 | $14 |
| Propranolol | 15 | $300 | $20 |
| Fenofibrate | 12 | $261 | $22 |
| Indomethacin | 13 | $201 | $15 |
| Fludrocortisone Acetate | 12 | $197 | $16 |
| Atenolol | 42 | $180 | $4 |
| Losartan-Hydrochlorothiazide | 14 | $127 | $9 |
| Amlodipine Besylate-Benazepril | 12 | $127 | $11 |
| Famotidine | 11 | $67 | $6 |
| Jantoven | 14 | $59 | $4 |
| Pantoprazole | 12 | $40 | $3 |
Year by year
| 2024 | 6,261 | 949 | 0% (0) | 14% | $1,182,524 |
| 2023 | 5,150 | 812 | 0% (0) | 15% | $1,064,062 |
| 2022 | 5,024 | 698 | 0% (0) | 16% | $1,028,473 |
| 2021 | 5,062 | 646 | 0% (0) | 18% | $995,696 |
| 2020 | 4,298 | 537 | 0% (0) | 20% | $734,403 |
| 2019 | 3,597 | 464 | 0% (0) | 19% | $566,349 |
| 2018 | 2,493 | 322 | 0% (0) | 19% | $327,075 |
| 2017 | 1,144 | 216 | 0% (0) | 21% | $117,653 |
| 2016 | 302 | 93 | 0% (0) | 26% | $25,110 |
| 2015 | 246 | 62 | 0% (0) | 33% | $12,307 |
| 2014 | 115 | 36 | 0% (0) | 28% | $8,650 |
| 2013 | 68 | 22 | None | 25% | $7,659 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 49 drugs
| Eliquis | 368 | $525,885 | $1,429 |
| Xarelto | 178 | $205,598 | $1,155 |
| Multaq | 31 | $52,509 | $1,694 |
| Repatha Sureclick | 30 | $39,811 | $1,327 |
| Entresto | 21 | $31,563 | $1,503 |
| Brilinta | 16 | $18,810 | $1,176 |
| Praluent | 14 | $17,742 | $1,267 |
| Livalo | 12 | $11,707 | $976 |
| Ezetimibe | 225 | $11,624 | $52 |
| Metoprolol | 507 | $11,035 | $22 |
| Atorvastatin | 628 | $9,434 | $15 |
| Rosuvastatin | 338 | $9,280 | $27 |
| Nebivolol | 36 | $5,372 | $149 |
| Amlodipine Besylate | 473 | $4,659 | $10 |
| Losartan | 255 | $4,619 | $18 |
| Diltiazem 24hr Er (Cd) | 68 | $3,696 | $54 |
| Digoxin | 74 | $3,105 | $42 |
| Warfarin | 53 | $2,566 | $48 |
| Potassium Chloride | 78 | $2,489 | $32 |
| Pravastatin | 90 | $2,150 | $24 |
| Lisinopril | 167 | $2,125 | $13 |
| Carvedilol | 110 | $1,834 | $17 |
| Omega-3 Acid Ethyl Esters | 19 | $1,718 | $90 |
| Isosorbide Mononitrate Er | 63 | $1,521 | $24 |
| Clopidogrel | 63 | $1,364 | $22 |
| Irbesartan | 48 | $1,360 | $28 |
| Olmesartan Medoxomil | 38 | $1,341 | $35 |
| Metoprolol | 126 | $1,293 | $10 |
| Hydralazine | 50 | $1,223 | $24 |
| Telmisartan | 19 | $1,094 | $58 |
| Candesartan Cilexetil | 13 | $1,069 | $82 |
| Hydrochlorothiazide | 146 | $1,065 | $7 |
| Furosemide | 160 | $1,019 | $6 |
| Verapamil Er | 17 | $1,003 | $59 |
| Diltiazem | 13 | $1,002 | $77 |
| Torsemide | 15 | $903 | $60 |
| Ramipril | 33 | $802 | $24 |
| Chlorthalidone | 23 | $650 | $28 |
| Propranolol | 17 | $569 | $33 |
| Spironolactone | 39 | $529 | $14 |
| Amiodarone | 24 | $481 | $20 |
| Nitroglycerin | 24 | $457 | $19 |
| Benazepril | 22 | $374 | $17 |
| Simvastatin | 27 | $366 | $14 |
| Fenofibrate | 15 | $344 | $23 |
| Triamterene-Hydrochlorothiazid | 19 | $269 | $14 |
| Atenolol | 26 | $219 | $8 |
| Losartan-Hydrochlorothiazide | 13 | $215 | $17 |
| Sotalol | 13 | $156 | $12 |
2022: 46 drugs
| Eliquis | 375 | $490,914 | $1,309 |
| Xarelto | 165 | $212,549 | $1,288 |
| Multaq | 34 | $51,308 | $1,509 |
| Entresto | 26 | $38,733 | $1,490 |
| Repatha Sureclick | 27 | $30,799 | $1,141 |
| Pradaxa | 11 | $16,133 | $1,467 |
| Ezetimibe | 211 | $15,385 | $73 |
| Vascepa | 13 | $13,660 | $1,051 |
| Rosuvastatin | 342 | $11,906 | $35 |
| Metoprolol | 458 | $9,977 | $22 |
| Atorvastatin | 594 | $8,185 | $14 |
| Nebivolol | 32 | $4,060 | $127 |
| Amlodipine Besylate | 480 | $3,466 | $7 |
| Digoxin | 77 | $3,407 | $44 |
| Losartan | 218 | $3,123 | $14 |
| Warfarin | 71 | $3,011 | $42 |
| Omega-3 Acid Ethyl Esters | 28 | $2,945 | $105 |
| Potassium Chloride | 93 | $2,810 | $30 |
| Diltiazem 24hr Er (Cd) | 64 | $2,783 | $43 |
| Pravastatin | 114 | $2,393 | $21 |
| Olmesartan Medoxomil | 48 | $2,279 | $47 |
| Irbesartan | 61 | $2,111 | $35 |
| Amiodarone | 33 | $2,090 | $63 |
| Isosorbide Mononitrate Er | 61 | $1,748 | $29 |
| Carvedilol | 114 | $1,650 | $14 |
| Lisinopril | 148 | $1,389 | $9 |
| Metoprolol | 123 | $1,133 | $9 |
| Furosemide | 159 | $1,095 | $7 |
| Hydralazine | 35 | $982 | $28 |
| Clopidogrel | 57 | $830 | $15 |
| Hydrochlorothiazide | 133 | $821 | $6 |
| Losartan-Hydrochlorothiazide | 19 | $784 | $41 |
| Chlorthalidone | 24 | $648 | $27 |
| Verapamil Er | 12 | $648 | $54 |
| Diltiazem | 13 | $581 | $45 |
| Nitroglycerin | 22 | $579 | $26 |
| Propranolol | 14 | $573 | $41 |
| Spironolactone | 35 | $546 | $16 |
| Sotalol | 19 | $541 | $28 |
| Simvastatin | 29 | $515 | $18 |
| Ramipril | 35 | $515 | $15 |
| Quinapril | 12 | $379 | $32 |
| Triamterene-Hydrochlorothiazid | 30 | $356 | $12 |
| Benazepril | 19 | $236 | $12 |
| Atenolol | 27 | $176 | $7 |
| Pantoprazole | 13 | $139 | $11 |
2021: 53 drugs
| Eliquis | 412 | $426,542 | $1,035 |
| Xarelto | 198 | $245,567 | $1,240 |
| Multaq | 30 | $45,365 | $1,512 |
| Pradaxa | 23 | $26,528 | $1,153 |
| Ezetimibe | 232 | $20,649 | $89 |
| Entresto | 11 | $18,862 | $1,715 |
| Bystolic | 46 | $16,303 | $354 |
| Vascepa | 21 | $16,094 | $766 |
| Praluent | 18 | $15,873 | $882 |
| Repatha Sureclick | 16 | $14,696 | $918 |
| Rosuvastatin | 338 | $12,312 | $36 |
| Livalo | 13 | $11,226 | $864 |
| Metoprolol | 447 | $10,324 | $23 |
| Atorvastatin | 575 | $9,428 | $16 |
| Losartan | 209 | $4,178 | $20 |
| Diltiazem 24hr Er (Cd) | 54 | $3,677 | $68 |
| Amlodipine Besylate | 495 | $3,438 | $7 |
| Omega-3 Acid Ethyl Esters | 25 | $3,360 | $134 |
| Potassium Chloride | 94 | $3,142 | $33 |
| Digoxin | 76 | $2,901 | $38 |
| Irbesartan | 60 | $2,835 | $47 |
| Warfarin | 75 | $2,679 | $36 |
| Amiodarone | 32 | $2,394 | $75 |
| Olmesartan Medoxomil | 39 | $2,098 | $54 |
| Pravastatin | 86 | $2,092 | $24 |
| Carvedilol | 121 | $1,918 | $16 |
| Nadolol | 15 | $1,718 | $115 |
| Chlorthalidone | 39 | $1,520 | $39 |
| Lisinopril | 151 | $1,484 | $10 |
| Clopidogrel | 63 | $1,276 | $20 |
| Isosorbide Mononitrate Er | 47 | $1,225 | $26 |
| Furosemide | 167 | $1,097 | $7 |
| Losartan-Hydrochlorothiazide | 25 | $1,050 | $42 |
| Metoprolol | 99 | $998 | $10 |
| Sotalol | 29 | $841 | $29 |
| Diltiazem 24hr Er | 11 | $817 | $74 |
| Hydrochlorothiazide | 92 | $673 | $7 |
| Ramipril | 24 | $624 | $26 |
| Hydralazine | 28 | $601 | $21 |
| Verapamil Er | 11 | $575 | $52 |
| Diltiazem | 12 | $479 | $40 |
| Propranolol | 15 | $471 | $31 |
| Levothyroxine | 13 | $468 | $36 |
| Torsemide | 15 | $460 | $31 |
| Spironolactone | 33 | $415 | $13 |
| Simvastatin | 30 | $390 | $13 |
| Omeprazole | 18 | $358 | $20 |
| Nitroglycerin | 14 | $347 | $25 |
| Benazepril | 22 | $346 | $16 |
| Triamterene-Hydrochlorothiazid | 23 | $286 | $12 |
| Famotidine | 13 | $230 | $18 |
| Atenolol | 26 | $180 | $7 |
| Terazosin | 11 | $157 | $14 |
2020: 49 drugs
| Eliquis | 297 | $269,144 | $906 |
| Xarelto | 178 | $188,541 | $1,059 |
| Multaq | 15 | $24,318 | $1,621 |
| Pradaxa | 18 | $21,494 | $1,194 |
| Bystolic | 66 | $20,455 | $310 |
| Entresto | 15 | $17,820 | $1,188 |
| Vascepa | 27 | $13,705 | $508 |
| Ezetimibe | 150 | $13,652 | $91 |
| Livalo | 16 | $12,672 | $792 |
| Rosuvastatin | 249 | $11,483 | $46 |
| Metoprolol | 350 | $11,056 | $32 |
| Atorvastatin | 498 | $9,839 | $20 |
| Praluent | 13 | $6,608 | $508 |
| Losartan | 196 | $3,780 | $19 |
| Warfarin | 96 | $3,676 | $38 |
| Irbesartan | 74 | $3,545 | $48 |
| Digoxin | 73 | $3,388 | $46 |
| Nadolol | 21 | $2,776 | $132 |
| Diltiazem 24hr Er (Cd) | 46 | $2,570 | $56 |
| Amlodipine Besylate | 366 | $2,503 | $7 |
| Omega-3 Acid Ethyl Esters | 21 | $2,412 | $115 |
| Potassium Chloride | 76 | $2,252 | $30 |
| Amiodarone | 47 | $2,148 | $46 |
| Olmesartan Medoxomil | 27 | $1,927 | $71 |
| Carvedilol | 105 | $1,857 | $18 |
| Chlorthalidone | 50 | $1,671 | $33 |
| Pravastatin | 55 | $1,564 | $28 |
| Lisinopril | 124 | $1,297 | $10 |
| Isosorbide Mononitrate Er | 50 | $1,288 | $26 |
| Furosemide | 156 | $1,177 | $8 |
| Cartia Xt | 21 | $1,057 | $50 |
| Ramipril | 34 | $925 | $27 |
| Metoprolol | 109 | $885 | $8 |
| Hydrochlorothiazide | 85 | $705 | $8 |
| Fenofibrate | 14 | $681 | $49 |
| Verapamil Er | 12 | $656 | $55 |
| Nitroglycerin | 18 | $639 | $35 |
| Losartan-Hydrochlorothiazide | 25 | $638 | $26 |
| Levothyroxine | 18 | $543 | $30 |
| Sotalol | 24 | $537 | $22 |
| Clopidogrel | 33 | $520 | $16 |
| Simvastatin | 27 | $423 | $16 |
| Hydralazine | 15 | $412 | $27 |
| Omeprazole | 15 | $309 | $21 |
| Benazepril | 21 | $247 | $12 |
| Triamterene-Hydrochlorothiazid | 18 | $224 | $12 |
| Spironolactone | 17 | $208 | $12 |
| Atenolol | 24 | $197 | $8 |
| Torsemide | 11 | $194 | $18 |
2019: 49 drugs
| Eliquis | 221 | $194,387 | $880 |
| Xarelto | 166 | $148,258 | $893 |
| Multaq | 21 | $21,317 | $1,015 |
| Welchol | 11 | $18,493 | $1,681 |
| Pradaxa | 26 | $15,152 | $583 |
| Bystolic | 38 | $11,906 | $313 |
| Praluent | 14 | $11,042 | $789 |
| Metoprolol | 275 | $10,363 | $38 |
| Ezetimibe | 97 | $10,098 | $104 |
| Atorvastatin | 380 | $8,262 | $22 |
| Rosuvastatin | 144 | $7,717 | $54 |
| Vascepa | 16 | $6,204 | $388 |
| Livalo | 16 | $6,191 | $387 |
| Ranolazine Er | 13 | $4,203 | $323 |
| Warfarin | 89 | $3,668 | $41 |
| Amlodipine Besylate | 357 | $3,644 | $10 |
| Nadolol | 28 | $3,162 | $113 |
| Irbesartan | 62 | $3,080 | $50 |
| Digoxin | 44 | $2,206 | $50 |
| Losartan | 147 | $2,195 | $15 |
| Enoxaparin | 12 | $1,977 | $165 |
| Diltiazem 24hr Er (Cd) | 43 | $1,935 | $45 |
| Olmesartan Medoxomil | 16 | $1,863 | $116 |
| Omega-3 Acid Ethyl Esters | 14 | $1,718 | $123 |
| Pravastatin | 51 | $1,555 | $30 |
| Carvedilol | 94 | $1,523 | $16 |
| Potassium Chloride | 36 | $1,425 | $40 |
| Diltiazem 24hr Er | 21 | $1,386 | $66 |
| Lisinopril | 138 | $1,363 | $10 |
| Chlorthalidone | 25 | $1,288 | $52 |
| Furosemide | 128 | $1,267 | $10 |
| Isosorbide Mononitrate Er | 59 | $1,177 | $20 |
| Ramipril | 30 | $1,076 | $36 |
| Metoprolol | 99 | $1,050 | $11 |
| Dilt-Xr | 16 | $994 | $62 |
| Hydrochlorothiazide | 112 | $865 | $8 |
| Fenofibrate | 18 | $856 | $48 |
| Sotalol | 18 | $475 | $26 |
| Cartia Xt | 12 | $464 | $39 |
| Spironolactone | 32 | $426 | $13 |
| Nitroglycerin | 18 | $424 | $24 |
| Clopidogrel | 26 | $386 | $15 |
| Losartan-Hydrochlorothiazide | 15 | $365 | $24 |
| Simvastatin | 24 | $360 | $15 |
| Benazepril | 18 | $334 | $19 |
| Levothyroxine | 12 | $298 | $25 |
| Torsemide | 11 | $280 | $25 |
| Atenolol | 19 | $200 | $11 |
| Triamterene-Hydrochlorothiazid | 16 | $199 | $12 |
2018: 40 drugs
| Eliquis | 122 | $90,293 | $740 |
| Xarelto | 116 | $87,787 | $757 |
| Multaq | 29 | $21,009 | $724 |
| Pradaxa | 29 | $12,882 | $444 |
| Ranexa | 18 | $9,143 | $508 |
| Ezetimibe | 51 | $7,419 | $145 |
| Metoprolol | 172 | $7,026 | $41 |
| Atorvastatin | 244 | $6,077 | $25 |
| Rosuvastatin | 89 | $4,662 | $52 |
| Warfarin | 84 | $3,389 | $40 |
| Enoxaparin | 14 | $2,970 | $212 |
| Amlodipine Besylate | 255 | $2,546 | $10 |
| Nadolol | 16 | $2,429 | $152 |
| Diltiazem 24hr Er (Cd) | 47 | $2,253 | $48 |
| Irbesartan | 38 | $1,623 | $43 |
| Digoxin | 24 | $1,556 | $65 |
| Chlorthalidone | 35 | $1,499 | $43 |
| Losartan | 103 | $1,352 | $13 |
| Pravastatin | 33 | $1,130 | $34 |
| Potassium Chloride | 30 | $1,104 | $37 |
| Lisinopril | 96 | $890 | $9 |
| Valsartan | 16 | $834 | $52 |
| Olmesartan Medoxomil | 15 | $813 | $54 |
| Diltiazem 24hr Er | 18 | $796 | $44 |
| Isosorbide Mononitrate Er | 40 | $772 | $19 |
| Clopidogrel | 41 | $768 | $19 |
| Ramipril | 23 | $738 | $32 |
| Nitroglycerin | 25 | $605 | $24 |
| Carvedilol | 40 | $545 | $14 |
| Metoprolol | 71 | $510 | $7 |
| Furosemide | 92 | $474 | $5 |
| Torsemide | 17 | $446 | $26 |
| Sotalol | 29 | $440 | $15 |
| Simvastatin | 27 | $379 | $14 |
| Spironolactone | 20 | $354 | $18 |
| Pantoprazole | 21 | $303 | $14 |
| Hydrochlorothiazide | 37 | $205 | $6 |
| Atenolol | 18 | $158 | $9 |
| Benazepril | 12 | $125 | $10 |
| Famotidine | 11 | $97 | $9 |
2017: 23 drugs
| Xarelto | 53 | $33,489 | $632 |
| Eliquis | 50 | $32,103 | $642 |
| Ranexa | 12 | $6,265 | $522 |
| Atorvastatin | 140 | $3,388 | $24 |
| Metoprolol | 77 | $2,890 | $38 |
| Rosuvastatin | 30 | $1,689 | $56 |
| Warfarin | 20 | $1,482 | $74 |
| Amlodipine Besylate | 103 | $874 | $8 |
| Diltiazem 24hr Er | 19 | $767 | $40 |
| Chlorthalidone | 11 | $671 | $61 |
| Losartan | 50 | $624 | $12 |
| Lisinopril | 58 | $545 | $9 |
| Carvedilol | 37 | $533 | $14 |
| Clopidogrel | 31 | $505 | $16 |
| Metoprolol | 68 | $456 | $7 |
| Pantoprazole | 20 | $378 | $19 |
| Sotalol | 17 | $321 | $19 |
| Torsemide | 11 | $297 | $27 |
| Levothyroxine | 14 | $243 | $17 |
| Potassium Chloride | 16 | $192 | $12 |
| Furosemide | 46 | $158 | $3 |
| Atenolol | 13 | $106 | $8 |
| Famotidine | 11 | $52 | $5 |
2016: 8 drugs
| Eliquis | 11 | $8,099 | $736 |
| Atorvastatin | 35 | $1,278 | $37 |
| Metoprolol | 40 | $438 | $11 |
| Lisinopril | 29 | $405 | $14 |
| Furosemide | 16 | $246 | $15 |
| Clopidogrel | 11 | $239 | $22 |
| Carvedilol | 19 | $211 | $11 |
| Amlodipine Besylate | 15 | $206 | $14 |
2015: 9 drugs
| Digoxin | 12 | $1,266 | $105 |
| Atorvastatin | 26 | $963 | $37 |
| Pantoprazole | 13 | $498 | $38 |
| Furosemide | 25 | $398 | $16 |
| Metoprolol | 29 | $335 | $12 |
| Lisinopril | 21 | $264 | $13 |
| Amlodipine Besylate | 11 | $252 | $23 |
| Isosorbide Mononitrate Er | 13 | $162 | $12 |
| Carvedilol | 12 | $140 | $12 |
2014: 2 drugs
| Lisinopril | 20 | $242 | $12 |
| Carvedilol | 11 | $125 | $11 |
Money from drug and device companies
$107 in 2025
| 2025 | 3 | 4 | None | $107 |
| 2024 | 6 | 16 | None | $1,138 |
| 2023 | 2 | 2 | None | $43 |
| 2022 | 5 | 7 | None | $300 |
| 2021 | 2 | 3 | None | $84 |
| 2020 | 2 | 18 | None | $1,482 |
| 2019 | 11 | 15 | None | $512 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Watchman Flx | $69 | 2 payments
|
| Abbott Laboratories | Pressurewire | $24 | 1 payment
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $14 | 1 payment
|
See all 4 published payments
| Abbott Laboratories | Meals · 2025-11-26 | Pressurewire | $24 |
| Boston Scientific | Meals · 2025-07-02 | Watchman Flx | $36 |
| Boston Scientific | Meals · 2025-02-18 | Watchman Flx | $34 |
| Cardiva Medical | Meals · 2025-01-16 | Cardiva Vascade Mvp Vvcs 6-12f | $14 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,138
| Edwards Lifesciences | Pascal | $733 | 8 payments
|
| Mirum Pharmaceuticals | Livmarli | $151 | 1 payment
|
| Boston Scientific | Watchman Flx | $110 | 3 payments
|
| Heartflow | Ffrct | $105 | 2 payments
|
| Abbott Laboratories | Mitraclip | $23 | 1 payment
|
| Cardiva Medical | Cardiva Vascade 6/7f Vcs | $16 | 1 payment
|
2023: $43
| Teleflex | Manta | $28 | 1 payment
|
| Abbott Laboratories | Mitraclip | $15 | 1 payment
|
2022: $300
| Abbott Laboratories | Mitraclip | $182 | 3 payments
|
| Boston Scientific | Watchman Access System | $40 | 1 payment
|
| HeartFlow | Ffrct | $32 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $28 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $18 | 1 payment
|
2021: $84
| Boston Scientific | Watchman | $57 | 2 payments
|
| Abbott Laboratories | Mitraclip System | $27 | 1 payment
|
2020: $1,482
| Abbott Laboratories | Mitra Clip System | $1,455 | 17 payments
|
| Lantheus Medical Imaging | Definity | $26 | 1 payment
|
2019: $512
| HeartFlow | None | $196 | 2 payments
|
| Abbott Laboratories | Mitra Clip System | $112 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $63 | 4 payments
|
| Sanofi-Aventis U.S. | Praluent | $22 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $21 | 1 payment
|
| Amgen | Repatha | $21 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $17 | 1 payment
|
| Pfizer | Vyndaqel | $16 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $15 | 1 payment
|
| Boston Scientific | Watchman | $15 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $14 | 1 payment
|
Professional record
- NPI
- 1578847844
- Licence
- CA A118391California A118391: Current · expires 2027-06-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 2 Bon Air Rd Ste 100, Larkspur, CA, 94939
- NPI first listed
- 2011-10-05
- NPI last updated
- 2021-07-19
- NPI record certified
- 2021-07-19
This is when the NPI record was last certified, not a medical board exam.